Diabetes Susceptibility Gene Identified: Tomosyn-2 Regulates Insulin Secretion
Main Category: DiabetesAlso Included In: Obesity / Weight Loss / Fitness; Genetics
Article Date: 09 Oct 2011 - 0:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
A group of researchers from the University of Wisconsin-Madison has pinpointed a gene that confers diabetes susceptibility in obese mice. Published in the open-access journal PLoS Genetics, this study also shows that its protein tomosyn-2 acts as a brake on insulin secretion from the pancreas.
"It's too early for us to know how relevant this gene will be to human diabetes," says Alan Attie, who leads the group, "but the concept of negative regulation is one of the most interesting things to come out of this study and that very likely applies to humans."
In a properly tuned system, insulin secreted into the blood after eating helps maintain blood sugar at a safe level. Too little insulin (as in type 1 diabetes) or insulin resistance (as in type 2 diabetes) leads to high blood sugar and diabetic symptoms. Too much insulin can drive blood glucose dangerously low and lead to coma or even death. The group found tomosyn-2 while searching for genes that contribute to diabetes susceptibility in obese mice. Genetic analyses and comparisons of obese diabetes-resistant and diabetes-susceptible mouse strains revealed a single amino acid difference that destabilizes the tomosyn-2 protein in the diabetes-resistant mice, effectively releasing the brake on insulin secretion and allowing those animals to release enough insulin to avoid diabetes.
Though diabetes is highly unlikely to be caused by a single gene, identifying important biological pathways can suggest clinically useful targets. "This study shows the power of genetics to discover new mechanisms for a complex disease like type 2 diabetes," concludes Sushant Bhatnagar, a co-lead author of the paper.
Visit our diabetes section for the latest news on this subject.
COMPETING INTERESTS: The authors have declared that no competing interests exist.
CITATION: Bhatnagar S, Oler AT, Rabaglia ME, Stapleton DS, Schueler KL, et al. (2011) Positional Cloning of a Type 2 Diabetes Quantitative Trait Locus; Tomosyn-2, a Negative Regulator of Insulin Secretion. PLoS Genet 7(10): e1002323. doi:10.1371/journal.pgen.1002323
Public Library of Science
MLA
23 Feb. 2012. <http://www.medicalnewstoday.com/releases/235634.php>
APA
http://www.medicalnewstoday.com/releases/235634.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




